<DOC>
	<DOC>NCT02595398</DOC>
	<brief_summary>The study is designed to evaluate the safety and efficacy of suprachoroidally administered triamcinolone acetonide, CLS-TA, in subjects with macular edema associated with non-infectious uveitis.</brief_summary>
	<brief_title>Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis</brief_title>
	<detailed_description>This is a Phase 3, randomized, masked, sham-controlled, multicenter study to assess the safety and efficacy of 4 mg of CLS-TA administered via suprachoroidal injection compared to a sham injection procedure in the treatment of subjects with macular edema associated with non-infectious uveitis. Qualified subjects will be randomized to receive two suprachoroidal injections of CLS-TA administered to the study eye or two sham injection procedures administered to the study eye approximately 12 weeks apart (Visit 2 and Visit 5). Follow-up visits will be conducted monthly up to 24 weeks (Visit 8).</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Panuveitis</mesh_term>
	<mesh_term>Uveitis, Posterior</mesh_term>
	<mesh_term>Uveitis, Intermediate</mesh_term>
	<mesh_term>Pars Planitis</mesh_term>
	<mesh_term>Uveitis, Anterior</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Diagnosis of noninfectious uveitis (pan, anterior, intermediate and posterior) Diagnosis of macular edema associated with noninfectious uveitis Visual Acuity score of ≥ 5 letters read (20/800 Snellen equivalent) and ≤ 70 letters read (20/40 Snellen equivalent), in the study eye Any active ocular disease or infection in the study eye other than uveitis Intraocular pressure &gt; 22 mmHg or uncontrolled glaucoma in the study eye Any uncontrolled systemic disease that, in the opinion of the Investigator, would preclude participation in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>UME</keyword>
	<keyword>Posterior Uveitis</keyword>
	<keyword>Anterior Uveitis</keyword>
	<keyword>Intermediate Uveitis</keyword>
	<keyword>Panuveitis</keyword>
	<keyword>Non-infectious Uveitis</keyword>
	<keyword>Triamcinolone</keyword>
	<keyword>Choroid</keyword>
	<keyword>Choroidal Injection</keyword>
	<keyword>Suprachoroidal</keyword>
	<keyword>Microneedle</keyword>
	<keyword>Microinjection</keyword>
</DOC>